Literature DB >> 3284548

Postirradiation sarcoma in retinoblastoma. Induction or predisposition?

M B Schwarz1, L P Burgess, W E Fee, S S Donaldson.   

Abstract

An alarmingly high rate of postirradiation sarcomas following treatment for retinoblastoma has been described in the literature. We present four new cases and report 57 others from the English literature. Osteogenic sarcoma was the predominant histologic type (58%), followed by fibrosarcoma (21%) and various other sarcomas (21%). The average latency period between irradiation and development of the second primary (sarcoma) was 12.4 years. Irrespective of irradiation, a genetic linkage between retinoblastoma and osteogenic sarcoma on the 13q14 chromosome is recognized. Through a pleiotropic effect of this same chromosome, a predisposition for other sarcomas may exist as well. Finally, a strong role for radiation induction is proposed for all of these postirradiation sarcomas. This is based on the increased number of sarcomas arising in the field of prior irradiation (sites uncharacteristic of spontaneously occurring primary sarcomas) and the prolonged latency periods.

Entities:  

Mesh:

Year:  1988        PMID: 3284548     DOI: 10.1001/archotol.1988.01860180054029

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Anterior skull base surgery for secondary malignancies in retinoblastoma survivors: report of two cases.

Authors:  K Ichimura; K Nibu; T Tanaka; H Takekoshi; T Sasaki; M Taniguchi; T Nakatsuka
Journal:  Skull Base Surg       Date:  1997

2.  Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma.

Authors:  L Venkatraman; J R Goepel; K Steele; S P Dobbs; R W Lyness; W G McCluggage
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

3.  Radiation-associated malignant tumors of the chest wall.

Authors:  R E Schwarz; M Burt
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

4.  Second primary tumours in hereditary- and nonhereditary retinoblastoma patients treated with megavoltage external beam irradiation.

Authors:  S M Imhof; A C Moll; P Hofman; M P Mourits; J Schipper; K E Tan
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.